Literature DB >> 24282726

Treating stable ischemic heart disease with percutaneous coronary intervention - The debate continues.

Rishi Puri1, Stephen J Nicholls.   

Abstract

Entities:  

Year:  2012        PMID： 24282726      PMCID： PMC3839154          DOI： 10.3978/j.issn.2223-3652.2012.10.06

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN： 2223-3652


× No keyword cloud information.
  19 in total

1.  Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease.

Authors:  William F Fearon; Bernhard Bornschein; Pim A L Tonino; Raffaella M Gothe; Bernard De Bruyne; Nico H J Pijls; Uwe Siebert
Journal:  Circulation       Date:  2010-11-29       Impact factor: 29.690

2.  Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study.

Authors:  Nico H J Pijls; Pepijn van Schaardenburgh; Ganesh Manoharan; Eric Boersma; Jan-Willem Bech; Marcel van't Veer; Frits Bär; Jan Hoorntje; Jacques Koolen; William Wijns; Bernard de Bruyne
Journal:  J Am Coll Cardiol       Date:  2007-05-17       Impact factor: 24.094

3.  Comparative outcomes for patients who do and do not undergo percutaneous coronary intervention for stable coronary artery disease in New York.

Authors:  Edward L Hannan; Zaza Samadashvili; Kimberly Cozzens; Gary Walford; Alice K Jacobs; David R Holmes; Nicholas J Stamato; Jeffrey P Gold; Samin Sharma; Ferdinand J Venditti; Tia Powell; Spencer B King
Journal:  Circulation       Date:  2012-03-22       Impact factor: 29.690

4.  Simultaneous coronary pressure and flow velocity measurements in humans. Feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve.

Authors:  B de Bruyne; J Bartunek; S U Sys; N H Pijls; G R Heyndrickx; W Wijns
Journal:  Circulation       Date:  1996-10-15       Impact factor: 29.690

5.  Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials.

Authors:  Shamir R Mehta; Christopher P Cannon; Keith A A Fox; Lars Wallentin; William E Boden; Rudolf Spacek; Petr Widimsky; Peter A McCullough; David Hunt; Eugene Braunwald; Salim Yusuf
Journal:  JAMA       Date:  2005-06-15       Impact factor: 56.272

6.  Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis.

Authors:  Demosthenes G Katritsis; John P A Ioannidis
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

Review 7.  Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis.

Authors:  Thomas A Trikalinos; Alawi A Alsheikh-Ali; Athina Tatsioni; Brahmajee K Nallamothu; David M Kent
Journal:  Lancet       Date:  2009-03-14       Impact factor: 79.321

8.  Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty.

Authors:  N H Pijls; J A van Son; R L Kirkeeide; B De Bruyne; K L Gould
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690

9.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

10.  Transstenotic coronary pressure gradient measurement in humans: in vitro and in vivo evaluation of a new pressure monitoring angioplasty guide wire.

Authors:  B De Bruyne; N H Pijls; W J Paulus; P J Vantrimpont; S U Sys; G R Heyndrickx
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094
View more
  2 in total

1.  Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells.

Authors:  Izuagie Attairu Ikhapoh; Christopher J Pelham; Devendra K Agrawal
Journal:  Differentiation       Date:  2015-04-23       Impact factor: 3.880

2.  Patient's Radiation Exposure in Coronary Angiography and Angioplasty: The Impact of Different Projections.

Authors:  Alireza Farajollahi; Atena Rahimi; Ebrahim Khayati Shal; Samad Ghaffari; Morteza Ghojazadeh; Arezou Tajlil; Naser Aslanabadi
Journal:  J Cardiovasc Thorac Res       Date:  2014-12-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.